Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
September 19, 2017
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
Philipp Steven, Albert J Augustin, Gerd Geerling, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
December 16, 2014
Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Albert J Augustin, Frank G Holz, Christos Haritoglou, et al.
Eye (London, England)
|
July 20, 2019
Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data
Srinivas R Sadda, Joanna Campbell, Pravin U Dugel, et al.
American Journal of Ophthalmology
|
March 27, 2017
Reply
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
American Journal of Ophthalmology
|
September 21, 2016
Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
Retina (Philadelphia, Pa.)
|
February 24, 2018
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data
Pravin U Dugel, Joanna H Campbell, Szilárd Kiss, et al.
European Journal of Ophthalmology
|
March 20, 2019
Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN<sup>®</sup> (0.19 mg fluocinolone acetonide implant)
Albert J Augustin, Silvia Bopp, Martin Fechner, et al.
European Journal of Ophthalmology
|
May 5, 2021
The impact of vitrectomy on outcomes achieved with 0.19 mg fluocinolone acetonide implant in patients with diabetic macular edema
Albert J Augustin, Silvia Bopp, Martin Fechner, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
June 17, 2020
[Correction: Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal Injections]
Michael Janusz Koss, Matthias Bolz, Albert J Augustin, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
November 27, 2019
[Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal Injections]
Michael Janusz Koss, Matthias Bolz, Albert J Augustin, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
September 19, 2017
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
Philipp Steven, Albert J Augustin, Gerd Geerling, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
December 16, 2014
Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Albert J Augustin, Frank G Holz, Christos Haritoglou, et al.
Eye (London, England)
|
July 20, 2019
Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data
Srinivas R Sadda, Joanna Campbell, Pravin U Dugel, et al.
American Journal of Ophthalmology
|
March 27, 2017
Reply
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
American Journal of Ophthalmology
|
September 21, 2016
Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
Retina (Philadelphia, Pa.)
|
February 24, 2018
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data
Pravin U Dugel, Joanna H Campbell, Szilárd Kiss, et al.
European Journal of Ophthalmology
|
March 20, 2019
Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN<sup>®</sup> (0.19 mg fluocinolone acetonide implant)
Albert J Augustin, Silvia Bopp, Martin Fechner, et al.
European Journal of Ophthalmology
|
May 5, 2021
The impact of vitrectomy on outcomes achieved with 0.19 mg fluocinolone acetonide implant in patients with diabetic macular edema
Albert J Augustin, Silvia Bopp, Martin Fechner, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
June 17, 2020
[Correction: Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal Injections]
Michael Janusz Koss, Matthias Bolz, Albert J Augustin, et al.
Klinische Monatsblatter Fur Augenheilkunde
|
November 27, 2019
[Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal Injections]
Michael Janusz Koss, Matthias Bolz, Albert J Augustin, et al.
Page
of 6